MSI-L

Clinical trials for MSI-L explained in plain language.

Never miss a new study

Get alerted when new MSI-L trials appear

Sign up with your email to follow new studies for MSI-L, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Promising combo may boost immune attack on hard-to-treat rectal cancer

Disease control Recruiting now

This study tests whether combining an immunotherapy drug (serplulimab) with chemotherapy (CAPEOX) and an anti-inflammatory drug (celecoxib) can shrink locally advanced rectal cancer before surgery. It includes 50 adults whose tumors are a common type that often doesn't respond we…

Matched conditions: MSI-L

Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control

Last updated Apr 30, 2026 15:51 UTC

MSI-L

Get alerted when new MSI-L trials appear

Promising combo may boost immune attack on hard-to-treat rectal cancer